Automated Insulin Delivery Systems in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
Automatisierte Insulinabgabesysteme bei Diabetes mellitus Typ 2: systematische Übersichtsarbeit und Metaanalyse
Diabetes Care · 01.06.2026 · 49 (6) · 1134-1143
DOI: 10.2337/dc25-2435 ↗Auf einen Blick
AID-Systeme verbesserten bei Menschen mit Typ-2-Diabetes unter Insulintherapie die Glukosekontrolle und reduzierten Hypoglykämie.
Fragestellung
Welche Effekte haben automatisierte Insulinabgabesysteme auf glykämische Endpunkte bei Menschen mit Typ-2-Diabetes, die Insulin benötigen?
Methode
Systematische Übersichtsarbeit und Metaanalyse; Suche in PubMed, Embase, Cochrane Library und ClinicalTrials.gov bis 10. März 2025; random-Effects-Single-Arm-Metaanalyse.
Ergebnisse
9 Studien mit 1.530 Teilnehmenden. TIR +16,06 % (95 %-KI 10,48–21,65), TAR −15,90 % (95 %-KI −21,44 bis −10,36), HbA1c −1,27 % (95 %-KI −2,06 bis −0,48), mittlere Glukose −21,34 mg/dL bzw. 1,19 mmol/L; TBR nahm moderat ab.
Einschränkungen
Heterogene Studiendesigns, darunter nur 3 RCTs, und imputierte fehlende Daten.
Schlussfolgerung der Autor:innen
AID-Systeme verbesserten die Glukosekontrolle bei einer diversen Population mit Typ-2-Diabetes unter Insulintherapie und reduzierten Hypoglykämie.
Kernaussagen
- TIR stieg um 16,06 %
- HbA1c sank um 1,27 %
- TBR nahm moderat ab
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift Diabetes Care, online erschienen am 06.04.2026. Verfasst von Larissa C Hespanhol und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Federal University of Campina Grande, Cajazeiras, Paraíba, Brazil. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin, Insulin Infusion Systems, Hypoglycemic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND Automated insulin delivery (AID) systems are the standard of care in type 1 diabetes. Recent studies suggest benefits of these systems for people with type 2 diabetes, as well. PURPOSE To evaluate the effects of AID systems on glycemic outcomes in people with type 2 diabetes requiring insulin. DATA SOURCES The PubMed, Embase, Cochrane Library, and ClinicalTrials.gov databases were searched through 10 March 2025. This study was registered with PROSPERO (CRD420251036184). STUDY SELECTION Nine studies (n = 1,530 participants) were included that evaluated AID systems in people with type 2 diabetes reporting continuous glucose monitoring outcomes. DATA EXTRACTION Data were collected on study characteristics and outcomes including time in range (TIR) (3.9–10.0 mmol/L [70–180 mg/dL]), time above range (TAR) (>10.0 mmol/L [>180 mg/dL]), time below range (TBR) (<3.9 mmol/L [<70 mg/dL]), mean glucose, and HbA1c. We performed a single-arm meta-analysis using a random-effects model. DATA SYNTHESIS AID systems significantly increased TIR by 16.06% (95% CI 10.48–21.65), changed TAR by −15.90% (95% CI –21.44 to –10.36), changed HbA1c by −1.27% (95% CI –2.06 to –0.48), and changed mean glucose by −21.34 mg/dL (95% CI –32.06 to –10.62) or 1.19 mmol/L (95% CI –1.78 to –0.59). There was a modest yet significant reduction in TBR. There were no changes in body weight or BMI. LIMITATIONS Heterogeneous study designs, including only three randomized controlled trials, and imputed missing data. CONCLUSIONS AID systems improved glucose control in a diverse population of individuals with type 2 diabetes requiring insulin therapy with reduction in hypoglycemia. These findings support recommendations for AID systems use in future type 2 diabetes management guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Federal University of Campina Grande, Cajazeiras, Paraíba, Brazil.
- Department of Internal Medicine, Division of Diabetes, Endocrinology & Metabolism, University of Nebraska Medical Center, Omaha, NE.
- Department of Internal Medicine, Federal University of Campina Grande, Paraíba, Brazil.
- Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH.
- Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Miami, Miami, FL.
- Department of Internal Medicine, Division of Endocrinology, University of Texas Southwestern, Dallas, TX.
ORCID-Profile: Larissa C Hespanhol, Shubham Agarwal, Rodolfo J Galindo, Marconi Abreu
Zitieren
APA
Hespanhol, L. C., Agarwal, S., Carvalhal, G., de Mendonça Bisneto, O. I., Chagas, G. C. L., Galindo, R. J., & Abreu, M. (2026). Automated Insulin Delivery Systems in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis. Diabetes Care, 49(6), 1134-1143. https://doi.org/10.2337/dc25-2435
Vancouver
Hespanhol LC, Agarwal S, Carvalhal G, de Mendonça Bisneto OI, Chagas GCL, Galindo RJ, et al. Automated Insulin Delivery Systems in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis. Diabetes Care. 2026;49(6):1134-1143. doi:10.2337/dc25-2435
BibTeX
@article{Hespanhol2026,
author = {Hespanhol, Larissa C and Agarwal, Shubham and Carvalhal, Giulia and de Mendonça Bisneto, Oscar Inácio and Chagas, Gabriel Cavalcante Lima and Galindo, Rodolfo J and Abreu, Marconi},
title = {Automated Insulin Delivery Systems in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis},
journal = {Diabetes Care},
year = {2026},
volume = {49},
number = {6},
pages = {1134--1143},
doi = {10.2337/dc25-2435}
}
EUVIMED